Both in Medical Labs
Exagen vs Sera Prognostics
Over the past year XGN returned −29.3% and SERA returned −36.3%; their daily moves had a correlation of 0.06.
XGN −29.3% SERA −36.3%Growth of $1, one year, split-adjusted
| Metric | XGN | SERA |
|---|---|---|
| Price | $8.37 | $2.04 |
| Market cap | $202.6M | $80.5M |
| Today | −2.62% | 0.00% |
| 1 month | +2.4% | −2.4% |
| 6 months | +169.8% | +7.4% |
| Year to date | +37.6% | −30.8% |
| 1 year | −28.9% | −39.1% |
| Revenue growth (YoY) | +15.9% | +76.5% |
| Gross margin | 61.3% | −66.7% |
| Net margin | −16.0% | −30463.3% |
| P/E (TTM) | — | — |
| Price / sales | 2.8× | 1,149.7× |
| Net cash | -$959.0K | $46.4M |
| Dividend yield | — | — |
| Volatility (60d) | 57.0% | 32.6% |
| Short % of float | 3.9% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).